PURPOSE: An enhanced version of the ProFit fitting tool was developed and validated to improve the quantification of two-dimensional JRPESS spectroscopic data. METHODS: The proposed enhancements were achieved by flexible organization of prior knowledge, configurations for different situations, the inclusion of measured macromolecular baseline contribution, additional baseline splines and a model-free lineshape based on self-deconvolution. The new software was tested and tuned on simulated data and subsequently applied to in vivo intrasubject and intersubject data. RESULTS: Fit results of simulated and acquired spectra show good overall quality suggesting the potential reliable detection of up to 18 metabolites on a 3T system yielding Cramer-Lower-Bounds below 20%. CONCLUSION: The proposed enhanced version of ProFit together with two-dimensional J-resolved spectroscopy offers the opportunity to reliably detect a wide selection of important brain metabolites on 3T.
PURPOSE: An enhanced version of the ProFit fitting tool was developed and validated to improve the quantification of two-dimensional JRPESS spectroscopic data. METHODS: The proposed enhancements were achieved by flexible organization of prior knowledge, configurations for different situations, the inclusion of measured macromolecular baseline contribution, additional baseline splines and a model-free lineshape based on self-deconvolution. The new software was tested and tuned on simulated data and subsequently applied to in vivo intrasubject and intersubject data. RESULTS: Fit results of simulated and acquired spectra show good overall quality suggesting the potential reliable detection of up to 18 metabolites on a 3T system yielding Cramer-Lower-Bounds below 20%. CONCLUSION: The proposed enhanced version of ProFit together with two-dimensional J-resolved spectroscopy offers the opportunity to reliably detect a wide selection of important brain metabolites on 3T.
Authors: Victor Adalid; André Döring; Sreenath Pruthviraj Kyathanahally; Christine Sandra Bolliger; Chris Boesch; Roland Kreis Journal: MAGMA Date: 2017-04-05 Impact factor: 2.310
Authors: Florian Riese; Anton Gietl; Niklaus Zölch; Anke Henning; Ruth O'Gorman; Andrea M Kälin; Sandra E Leh; Alfred Buck; Geoffrey Warnock; Richard A E Edden; Roger Luechinger; Christoph Hock; Spyros Kollias; Lars Michels Journal: Neurobiol Aging Date: 2014-07-29 Impact factor: 4.673
Authors: Katrin H Preller; Thomas Pokorny; Andreas Hock; Rainer Kraehenmann; Philipp Stämpfli; Erich Seifritz; Milan Scheidegger; Franz X Vollenweider Journal: Proc Natl Acad Sci U S A Date: 2016-04-18 Impact factor: 11.205
Authors: Paul M Macey; Manoj K Sarma; Janani P Prasad; Jennifer A Ogren; Ravi Aysola; Ronald M Harper; M Albert Thomas Journal: Neuroscience Date: 2017-09-08 Impact factor: 3.590
Authors: Matti Gärtner; Anne Weigand; Milan Scheidegger; Mick Lehmann; Patrik O Wyss; Andreas Wunder; Anke Henning; Simone Grimm Journal: Eur Arch Psychiatry Clin Neurosci Date: 2022-01-12 Impact factor: 5.760
Authors: Zohaib Iqbal; Neil E Wilson; Margaret A Keller; David E Michalik; Joseph A Church; Karin Nielsen-Saines; Jaime Deville; Raissa Souza; Mary-Lynn Brecht; M Albert Thomas Journal: PLoS One Date: 2016-09-13 Impact factor: 3.240
Authors: Márcio Gerhardt Soeiro-de-Souza; Bruno F Pastorello; Cláudia da Costa Leite; Anke Henning; Ricardo A Moreno; Maria Concepción Garcia Otaduy Journal: Int J Neuropsychopharmacol Date: 2016-08-12 Impact factor: 5.176